Hefei Lifeon Pharmaceutical Management
Management criteria checks 2/4
Hefei Lifeon Pharmaceutical's CEO is Huanxi Cui, appointed in May 2023, has a tenure of 2.5 years. directly owns 0.082% of the company’s shares, worth CN¥4.94M. The average tenure of the management team and the board of directors is 3.8 years and 3.3 years respectively.
Key information
Huanxi Cui
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.08% |
| Management average tenure | 3.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 05
Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet
Sep 30Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50
May 23Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump
May 22Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues
Apr 29CEO
Huanxi Cui (46 yo)
Mr. Huanxi Cui is General Manager of Hefei Lifeon Pharmaceutical Co. Ltd. from May 8, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager | 2.5yrs | CN¥1.77m | 0.082% CN¥ 4.9m | |
| Financial Director | 7.5yrs | CN¥446.40k | 0.035% CN¥ 2.1m | |
| R&D Director & Non-Independent Director | no data | CN¥265.20k | 0.071% CN¥ 4.2m | |
| Deputy GM & Non-Independent Director | 4.3yrs | CN¥549.20k | 0.68% CN¥ 40.7m | |
| Deputy General Manager | 3.3yrs | CN¥570.70k | 0.30% CN¥ 18.1m | |
| Deputy GM & Secretary of the Board | no data | CN¥433.60k | 0.036% CN¥ 2.1m |
Experienced Management: 003020's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| R&D Director & Non-Independent Director | 15.3yrs | CN¥265.20k | 0.071% CN¥ 4.2m | |
| Deputy GM & Non-Independent Director | 4.2yrs | CN¥549.20k | 0.68% CN¥ 40.7m | |
| Independent Director | 5.2yrs | CN¥72.00k | no data | |
| Vice Chairman | no data | CN¥694.60k | 7.04% CN¥ 424.0m | |
| Chairman of the Board | no data | CN¥671.70k | 46.95% CN¥ 2.8b | |
| Supervisory Board Chairman | no data | CN¥596.60k | 0.30% CN¥ 18.2m | |
| Employee Supervisor | no data | no data | 0.22% CN¥ 13.1m | |
| Independent Director | 3.3yrs | CN¥72.00k | no data | |
| Non-Employee Supervisor | 3.3yrs | no data | no data | |
| Independent Director | 2yrs | CN¥72.00k | no data | |
| Non-Independent Director | less than a year | no data | no data |
Experienced Board: 003020's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 02:36 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hefei Lifeon Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xinming Zhou | Topsperity Securities |